Evidence map›Paper›PMID 37008721›Full record

ArticleFood chemistry: X2023

Preparation and in vitro evaluation of hesperidin nanoparticles by antisolvent recrystallization in a double homogenate system.

Xiaonan Zhang, Zhiwei Liu, Yan Huang, Yaqian Niu, Lubin Zhang, Tingting Xiong, Yingdi Zhang, Ruizhi Zhang, Huajiang Zhang

Open access · goldAbstract read
In one paragraph

Article in Food chemistry: X, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiaonan ZhangCollege of Life Science, Jiaying University, Meizhou 514015, China.
Zhiwei LiuCollege of Life Science, Jiaying University, Meizhou 514015, China.
Yan HuangCollege of Life Science, Jiaying University, Meizhou 514015, China.
Yaqian NiuCollege of Life Science, Jiaying University, Meizhou 514015, China.
Lubin ZhangCollege of Life Science, Jiaying University, Meizhou 514015, China.
Tingting XiongCollege of Life Science, Jiaying University, Meizhou 514015, China.
Yingdi ZhangCollege of Life Science, Jiaying University, Meizhou 514015, China.
Ruizhi ZhangCollege of Life Science, Jiaying University, Meizhou 514015, China.
Huajiang ZhangNortheast Agricultural University, Harbin 150030, China.
Jiaying University · CNNortheast Agricultural University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hesperidin nanoparticles (HNPs) were made for the first time employing an antisolvent recrystallization technique in a double homogenate system with positive and negative clockwise rotation in order to completely use the underutilized nutritional components in citrus peel. Dimethyl sulfoxide (DMSO), ethanol, and deionized water were used as the solvents and antisolvents in the hesperidin solution preparation. Hesperidin solution concentration of 60.26 mg/mL, homogenization speed of 8257 rpm, antisolvent-to-solvent volume ratio of 6.93 mL/mL, and homogenization time of 3.15 min were the ideal experimental conditions. HNPs have to be at least 72.24 nm in size. The structures of the produced hesperidin samples and the raw hesperidin powder were identical, according to the findings of the FTIR, XRD, and TG characterization tests. The HNP sample had an in vitro absorption rate that was 5.63 and 4.23 times greater than that of the raw hesperidin powder, respectively. It was discovered that DMSO was more suited than ethanol for creating HNP particles. In the realms of dietary supplements, therapeutic applications, and health promotion, the HNPs produced by the ARDH technology would be a potential formulation on increasing uses for a wider range of nutraceuticals (synergistic).

Indexed as

Antisolvent recrystallizationDouble homogenateHesperidin nanoparticlesIn vitro

Identifiers

PMID37008721
PMCPMC10060592
OpenAlexW4324100948

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.